# SMOC Therapeutics, Inc. — Form D

SMOC Therapeutics, Inc. of NATICK, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-08. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2018-01-08
- Form: D
- Accession: 0001727186-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $7.5M
- Amount sold: $7.5M
- Investors: 1
- Date of first sale: 2017-12-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-302605

## Issuer

- Name: SMOC Therapeutics, Inc.
- CIK: 0001727186
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 21 STRATHMORE ROAD, NATICK, MA, 01760
- Phone: 617-256-0388

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Shjiang Lu | Director | Natick, MA |
| Yong Wang | Director | Natick, MA |
| Hao Wu | Director | Piedmont, SC |
| Kevin Sprott | Executive Officer | Natick, MA |
| Hao Wu | Executive Officer | Piedmont, SC |

## More

- [CIK 1727186 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1727186&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001727186-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.